Search

everythinglearnresearchcommunity

for

Search:↓

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Topical tofacitinib is effective and safe for treating alopecia areata.

Apremilast shows promise for several skin conditions but needs more research.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

CTE can distort results in hair growth trials, so exclude it carefully.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Hair gels may cause split ends in children.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

MPZL3 is crucial for seborrheic dermatitis development.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

Adalimumab may cause severe hair loss in some patients.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Nail loss may be a side effect of the MS drug teriflunomide.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

People with alopecia areata have higher insulin resistance.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

People with Alopecia Areata are more likely to have prediabetes and obesity.